Form 4 for BNGO Bionano Genomics, Inc.
Accepted 2023-02-17 00:00:00 ET · period of report 2023-02-15 · accession 0001209191-23-010918 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-17 | 2023-02-15 | BNGO | Stewart Christopher P. | CFO | A - Grant | $0.00 | +105.0K | 231.4K | +83% | $0 |
| D | 2023-02-17 | 2023-02-15 | BNGO | Stewart Christopher P. | CFO | A - Grant | $0.00 | +490.0K | 490.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-15 | A | A | 105,000 | $0.00 | 231,373 | D | — | — | (F1) Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan. (F2) Includes 2,285 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "ESPP") on June 10, 2022 and 2,509 shares acquired under the ESPP on December 10, 2022. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-02-15 | A | A | 490,000 | $0.00 | 490,000 | D | $1.63 · — to 2033-02-14 | 490,000 Common Stock | (F3) The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2023 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date. |